Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/58182
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel C.-
dc.contributor.authorPillsbury A.-
dc.contributor.authorNguyen T.-
dc.contributor.authorWang X.-
dc.contributor.authorQuinn H.E.-
dc.contributor.authorChiu C.K.-
dc.contributor.authorCheng A.C.-
dc.contributor.authorFlanagan K.L.-
dc.contributor.authorWang Z.-
dc.date.accessioned2026-05-06T22:43:56Z-
dc.date.available2026-05-06T22:43:56Z-
dc.date.copyright2026-
dc.date.issued2026-04-28en
dc.identifier.citationMedical Journal of Australia. 224(4) (no pagination), 2026. Article Number: e70188. Date of Publication: 01 Apr 2026.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/58182-
dc.description.abstractSeasonal influenza causes significant morbidity and mortality in Australia. Despite long-standing recommendations for influenza vaccination and nationally funded programs for higher risk age or population groups, coverage remains suboptimal, especially among children. Introduction of the intranasal live attenuated influenza vaccine (LAIV) in 2026 offers an additional safe and effective needle-free vaccine option. Easier administration may improve access by making delivery by a range of health care providers possible. This perspective article outlines the evidence supporting the use of the LAIV and its potential to improve vaccination uptake among children in Australia.Copyright © 2026 The Author(s). Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.-
dc.publisherJohn Wiley and Sons Inc-
dc.relation.ispartofMedical Journal of Australia-
dc.subject.meshAustralia-
dc.subject.meshchildhood disease-
dc.subject.meshcommunicable disease-
dc.subject.meshhealth care personnel-
dc.subject.meshhospitalization-
dc.subject.meshimmunization-
dc.subject.meshinfluenza-
dc.subject.meshinfluenza vaccination-
dc.subject.meshseasonal influenza-
dc.subject.meshvaccination-
dc.subject.meshvaccination coverage-
dc.titleThe Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention.-
dc.typeArticle-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=https://dx.doi.org/10.5694/mja2.70188-
dc.publisher.placeAustralia-
dc.identifier.pubmedid42002529-
dc.identifier.institution(Patel, Pillsbury, Wang, Quinn, Chiu, Wang) University of Sydney, Sydney, NSW, Australia-
dc.identifier.institution(Patel, Pillsbury, Nguyen, Wang, Quinn, Chiu, Wang) National Centre for Immunisation Research and Surveillance, Sydney, NSW, Australia-
dc.identifier.institution(Nguyen) UNSW Sydney, Sydney, NSW, Australia-
dc.identifier.institution(Cheng) Monash University, Melbourne, VIC, Australia-
dc.identifier.institution(Cheng) Monash Health, Melbourne, VIC, Australia-
dc.identifier.institution(Flanagan) Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, NSW, Australia-
dc.identifier.institution(Flanagan) University of Tasmania, Launceston, TAS, Australia-
dc.identifier.institution(Flanagan) RMIT University, Melbourne, VIC, Australia-
dc.identifier.affiliationmh(Cheng) Monash University, Melbourne, VIC, Australia-
dc.identifier.affiliationmh(Cheng) Monash Health, Melbourne, VIC, Australia-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptInfectious Diseases and Clinical Microbiology-
crisitem.author.deptMonash University - School of Public Health and Preventative Medicine-
Appears in Collections:Articles
Show simple item record

Page view(s)

28
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.